ASI 2017* , ,
Presentations this author is a contributor to:
Development of an in vivo model to study the effects of monoclonal antibody treatment of squamous cell carcinoma (#247)
4:00 PM
Xuzhi (Jessica) He
Poster Session Two
Investigating the role of CD8 T-cells in Rapamycin-mediated regression of squamous cell carcinoma (#350)
4:00 PM
Nicola Pett
Poster Session Three
The role of CD8+ T-cells in the regression of Squamous Cell Carcinoma (#418)
4:00 PM
Zhen ZENG
Poster Session Three
CESTEM-1 clinical trials: using dynamin inhibitors to reverse resistance to monoclonal antibody therapy. (49404)
3:20 PM
Fiona Simpson
Tumour Immunology Workshop Session V: Translational Immunotherapy